Final results of multicenter prospective observational study of nano-liposomal irinotecan, fluorouracil and folinic acid in second-line chemotherapy for advanced pancreatic cancer: The NAPOLEON-2

被引：0

作者：

Toyodome, K. ^{[1
]}

Arima, S. ^{[1
]}

Shimokawa, M. ^{[2
]}

Otsuka, T. ^{[3
]}

Nakazawa, J. ^{[4
]}

Shimokawa, H. ^{[5
]}

Koga, F. ^{[6
]}

Oda, H. ^{[7
]}

Takeshita, S. ^{[8
]}

Kawaguchi, Y. ^{[9
]}

Arita, S. ^{[10
]}

Nishikawa, K. ^{[11
]}

Jikuya, K. ^{[12
]}

Sakai, T. ^{[13
]}

Sawase, H. ^{[14
]}

Ueda, Y. ^{[15
]}

Araki, N. ^{[16
]}

Shirakawa, T. ^{[17
]}

Mizuta, T. ^{[18
]}

Mitsugi, K. ^{[19
]}

机构：

[1] Kagoshima Univ, Digest & Lifestyle Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan

[2] Yamaguchi Univ, Dept Biostat, Grad Sch Med, Yamaguchi, Japan

[3] Minato Med Clin, Dept Internal Med, Fukuoka, Japan

[4] Kagoshima City Hosp, Dept Med Oncol, Kagoshima, Japan

[5] Japan Community Healthcare Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan

[6] Saga Ken Med Ctr Koseikan, Dept Hepatobiliary & Pancreatol, Saga, Japan

[7] Saiseikai Kumamoto Hosp, Div Integrat Med Oncol, Kumamoto, Fukuoka, Japan

[8] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Gastroenterol, Nagasaki, Japan

[9] Asakura Med Assoc Hosp, Dept Gastroenterol, Fukuoka, Japan

[10] Miyazaki Prefectural Miyazaki Hosp, Dept Chemotherapy, Miyazaki, Japan

[11] Oita Univ, Dept Med Oncol & Hematol, Fac Med, Oita, Japan

[12] Imamura Gen Hosp, Dept Gastroenterol, Kagoshima, Japan

[13] Natl Hosp Org Kumamoto Med Ctr, Dept Med Oncol, Kumamoto, Japan

[14] Natl Hosp Org Saga Hosp, Dept Internal Med, Saga, Japan

[15] Japanese Red Cross Kumamoto Hosp, Dept Hematol & Oncol, Kumamoto, Japan

[16] Saiseikai Sendai Hosp, Dept Gastroenterol, Kagoshima, Japan

[17] Clin Hematol Oncol Treatment Study Grp, Fukuoka, Japan

[18] Fujikawa Hosp, Dept Internal Med, Saga, Japan

[19] Sasebo Kyosai Hosp, Dept Med Oncol, Nagasaki, Japan

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.488

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

346P

引用

页码：S144 / S144

页数：1

共 50 条

[41] SECOND-LINE CHEMOTHERAPY WITH FLUOROURACIL, LEUCOVORIN, AND IRINOTECAN (FOLFIRI REGIMEN) IN PATIENTS WITH ADVANCED SMALL BOWEL ADENOCARCINOMA AFTER FAILURE OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY: A MULTICENTER AGEO STUDY
Aparicio, T.
Zaanan, A.
Gauthier, M.
Malka, D.
Locher, C.
Gornet, J.
Thirot-Bidault, A.
Tougeron, D.
Taieb, J.
Bonnetain, F.
ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
[42] Scoring model with serum albumin and CA19-9 in advanced pancreatic cancer in second-line treatment: Results from the NAPOLEON study
Komori, Azusa
Otsu, Satoshi
Shimokawa, Mototsugu
Otsuka, Taiga
Koga, Futa
Ueda, Yujiro
Nakazawa, Junichi
Arima, Shiho
Fukahori, Masaru
Okabe, Yoshinobu
Makiyama, Akitaka
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Shirakawa, Tsuyoshi
Mitsugi, Kenji
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[43] Combination of paclitaxel, cisplatin, and fluorouracil in patients with advanced and metastatic gastric cancer as first- or second-line therapy: A multicenter prospective study.
Zhang, X.
Yongqian, S.
Zhang, F.
Liang, J.
Ma, X.
Chen, L.
Huang, J. J.
Shi, G.
Cao, W.
Shen, L.
Jin, M.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[44] Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter study
Zhang, Yan
Xu, Junying
Wang, Qiong
Ling, Guohong
Mao, Yong
Cai, Maohuai
Yang, Yang
Mei, Jingfeng
Han, Zhengxiang
Feng, Jifeng
Wu, Yuan
Shi, Lin
Wen, Shaodi
Shen, Bo
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (11)
[45] 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy
Lee, Min Geun
Lee, Sang Hyub
Lee, Seung June
Lee, Yoon Suk
Hwang, Jin-Hyeok
Ryu, Ji Kon
Kim, Yong-Tae
Kim, Dong Uk
Woo, Sang Myung
CHEMOTHERAPY, 2013, 59 (04) : 273 - 279
[46] The efficacy of fluoropyrimidine-based second line chemotherapy in advanced and metastatic pancreatic cancer: Results of an ongoing retrospective multicenter study
Mancuso, A.
Saletti, P.
Sacchetta, S.
Romagnani, E.
Aprile, G.
Fatigoni, S.
Garassino, M.
Saggese, M.
Cavalli, F.
Sternberg, C.
ANNALS OF ONCOLOGY, 2006, 17 : 61 - 61
[47] Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
Clarke, Stephen J.
Yip, Sonia
Brown, Chris
van Hazel, Guy A.
Ransom, David T.
Goldstein, David
Jeffrey, G. Mark
Tebbutt, Niall C.
Buck, Martin
Lowenthal, Raymond M.
Boland, Amy
Gebski, Val
Zalcberg, John
Simes, R. John
EUROPEAN JOURNAL OF CANCER, 2011, 47 (12) : 1826 - 1836
[48] Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer
Taira, Koichi
Boku, Narikazu
Fukutomi, Akira
Onozawa, Yusuke
Hironaka, Shuichi
Yoshino, Takayuki
Yasui, Hirofumi
Yamazaki, Kentaro
Taku, Keisei
Hashimoto, Takayuki
Nishimura, Tetsuo
JOURNAL OF GASTROENTEROLOGY, 2008, 43 (11) : 875 - 880
[49] Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer
Koichi Taira
Narikazu Boku
Akira Fukutomi
Yusuke Onozawa
Shuichi Hironaka
Takayuki Yoshino
Hirofumi Yasui
Kentaro Yamazaki
Keisei Taku
Takayuki Hashimoto
Tetsuo Nishimura
Journal of Gastroenterology, 2008, 43 : 875 - 880
[50] Final results of the randomized phase II study of sequential docetaxel and irinotecan with infusion 5-fluorouracil/folinic acid in patients with advanced gastric cancer - GA-TAC
Lind, P. A.
Gubanski, M.
Johnsson, A.
Fernebro, E.
Flygare, P.
Karlberg, I.
Kadar, L.
Glimelius, B.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →